What starts as an assumption of patient incompetence results in the erasure of autonomy from Black patients.
Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
The international news story that broke at AIDS 2020, explained by the lead researcher.
Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.
Our Newest Posts
An interview with Andrew Hill, Ph.D., about his research presented at AIDS 2020.
Research showing housing as part of public health in HIV has long been established. But now, experts are also seeing the connection to COVID-19.
This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect
Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.
July 30, 2020: HIV prevention shortfalls among adolescents of color; PrEP use among trans people; PrEP information gaps among women of color; the case for vacation-based (a.k.a. episodic) PrEP.
Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.
LaRon Nelson, Ph.D., RN, talks about public health’s responsibility to meet this extraordinary moment.